Xeris Biopharma Holdings Inc (XERS)
Operating Cash Flow (Statement)
$56.61M
TTM · Period ending: · USD
XERS Operating Cash Flow (Statement)
Latest reported$56.61Mperiod ending
Latest reported$56.61Mperiod ending
XERS Cash from Operations (-$16.09M → $56.61M)
Annual operating cash flow (statement)
High-resolution chart · PNG
XERS operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 28,626,000 | |
| -36,981,000 | |
| -47,023,000 | |
| -102,891,000 | |
| -95,535,000 | |
| -80,558,000 | |
| -80,558,000 | |
| -56,279,000 | |
| -24,663,000 | |
| -16,087,000 |